We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A test that picks up a nearly undetectable variation in the heartbeat helps single out heart attack survivors who are likely to develop potentially deadly heart rhythms, reports the June issue of the Harvard Heart Letter.
Boston Scientific Corporation June 6 announced that it has received FDA clearance to launch its Sterling Monorail and Over-the-Wire Balloon Dilatation Catheter in the United States.
Changes to Medicare reimbursement rules proposed by the Centers for Medicare & Medicaid (CMS) will compromise treatments for a range of serious heart conditions, the Heart Rhythm Society (HRS) has announced.
If the World Health Organization (WHO) has its way, diagnostic and drug firms in the world's most prosperous nations will develop and manufacture more products to diagnose and treat medical conditions in the world's poorer countries.
Ortec International, a company focused on development and commercialization of products applicable to regenerative medicine and stem cell therapy, June 1 announced that it has received notification from the U.S. patent office that the claims of its patent application on "Novel Haptotactic Peptides," related to its Haptides technology platform, have been allowed.
The largest Metered Dose Inhaler manufacturer of Bangladesh, Beximco Pharmaceuticals Limited (BPL), launched a novel, new-generation corticosteroid inhaler Cesonide Sunday for treatment of adults suffering from persistent asthma.
Massachusetts stands to gain the corporate headquarters of one of the world's largest medical device corporations -- capping the transformation of a company that has actually been here for years.
BioView Ltd., which develops and distributes automated scanning systems for the detection of cancer, has signed an agreement with the University of Texas MD Anderson Cancer Center for the joint development of an early diagnosis system for lung cancer among high risk population groups.